> The present paper (publication) concerns the synthesis of new isoxazole[4,5‐ d ]'/> Synthesis of New Isoxazolo[4,5‐ <i xmlns='http://www.wiley.com/namespaces/wiley'>dd ]pyrimidines as Antitumor Agents
首页> 外文期刊>Journal of Heterocyclic Chemistry: The International Journal of Heterocyclic Chemistry >Synthesis of New Isoxazolo[4,5‐ dd ]pyrimidines as Antitumor Agents
【24h】

Synthesis of New Isoxazolo[4,5‐ dd ]pyrimidines as Antitumor Agents

机译:新isoxazolo的综合[4,5- d d“嘧啶作为antritumor代理

获取原文
获取原文并翻译 | 示例
           

摘要

> The present paper (publication) concerns the synthesis of new isoxazole[4,5‐ d ]pyrimidine derivatives. There are only a few publications in the chemical literature that report the derivatives of the [4,5‐ d ] isomer. Our new compounds, the derivatives of this isomer, were obtained using a new manner that differs from those reported in the aforementioned publications in that we used the tautomers of 3‐arylo‐4‐imino‐5‐carbethoxy isxazole 3 and 4 as the starting compounds instead of using their 4‐amino forms. Their tautomeric form proved chemically stable, and, as a result of ammonolysis, we obtained the compounds 5 and 6 . The cyclization of the amides of 5 and 6 with various aldehydes yielded new derivatives, 10 – 19 , with good yields. As a by‐product, the 4‐amino tautomer form in by degrees and was reacted also with aldehydes, and we isolated Schiff bases 20 – 25 with low yields. Some of these compounds were tested for their antitumor activity at National Cancer Institute, Bethesda, MD, USA.
机译: >本文(出版物)涉及新的异恶唑的合成[4, 5- D ]嘧啶衍生物。化学文献中只有少数出版物报告了[4,5- D ]异构体的衍生物。我们的新化合物,这种异构体的衍生物,使用来自上述出版物中报道的那些不同的新的方式获得,因为我们使用的3-芳基-4-亚氨基-5-碳甲氧基苯甲氧唑的互变异构体 3 和 4 作为起始化合物,而不是使用它们的4-氨基形式。它们的互变异构形式被证明化学稳定,并且由于氨解,我们得到了化合物 5 / B>和 6 / B>。用各种醛的 5 / b>和 6 / b>的环化产生了新的衍生物, 10 - 19 ,具有良好的产量。作为副产物,4-氨基互变异构形式逐点形成并与醛相反,并且我们将席克夫碱分离为低产率。在美国国家癌症研究所,贝塞斯达,MD,MD,MD,MD的抗肿瘤活性测试了一些这些化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号